Robert Iannone - Jun 5, 2023 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
EVP, Global Head of Research a
Signature
By: Adam Guttman, as attorney in fact For: Robert Iannone
Stock symbol
JAZZ
Transactions as of
Jun 5, 2023
Transactions value $
-$170,076
Form type
4
Date filed
6/7/2023, 07:16 PM
Previous filing
May 4, 2023
Next filing
Jun 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Disposed to Issuer -$170K -1.31K -2.81% $129.73 45.3K Jun 5, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
F2 Includes 137 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2023.